Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | CD-1530 | CTRPv2 | pan-cancer | AAC | 0.0055 | 0.9 |
mRNA | SNX-2112 | CTRPv2 | pan-cancer | AAC | 0.0046 | 0.9 |
mRNA | PF-750 | CTRPv2 | pan-cancer | AAC | -0.0055 | 0.9 |
mRNA | AZD-2281 | CTRPv2 | pan-cancer | AAC | -0.0049 | 0.9 |
mRNA | alisertib | CTRPv2 | pan-cancer | AAC | -0.0044 | 0.9 |
mRNA | blebbistatin | CTRPv2 | pan-cancer | AAC | -0.01 | 0.9 |
mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | 0.0051 | 0.9 |
mRNA | LE-135 | CTRPv2 | pan-cancer | AAC | -0.0048 | 0.9 |
mRNA | BRD-K27986637 | CTRPv2 | pan-cancer | AAC | 0.0094 | 0.9 |
mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | 0.0045 | 0.9 |